Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Eli Lilly drug was rejected

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Jan 25, 2023 2:09pm

138 Views

Post# 35245819

RE:RE:RE:Eli Lilly drug was rejected

As you all can see mad losing fortunes mugsy will never answears the hard inconvinent questions though he know best. Yep he knows how to lose forture thogh I think he/she/it buys one share at the time to average down, By now 100 shares

<< Previous

Bullboard Posts

Next >>

AI companies to invest in